In 2008, Roche had over 80’000 employees worldwide and invested almost 9 billion Swiss francs in R&D.
The Group posted sales of 45.6 billion Swiss francs.
For more information: www.roche.com
OrbiMed is the world’s largest healthcare and life sciences-dedicated investment firm, with approximately $5 billion in assets under management. Since inception of its private equity investment activities in 1993, OrbiMed has successfully invested in over 100 private companies across a wide range of therapeutic categories and stages of development. OrbiMed’s investment team includes over 30 experienced professionals with backgrounds in science, medicine, industry, finance and law. OrbiMed launched the first pan-Asia healthcare and life sciences-dedicated venture capital fund in 2008, with close to $200 million in commitments. OrbiMed maintains offices in
For more information: www.OrbiMed.com
McKinsey & Company in Greater
With over 8,000 consultants deployed from over 90 offices in 50 countries, McKinsey & Company is a global management consulting firm that advises companies and public institutions on issues concerning strategy, organization, operations, and technology. McKinsey's Greater China Practice comprises offices in
ChinaBio® Accelerator was created to accelerate the globalization of China's biotechnology industry by:
ChinaBio is identifying promising biotech and medical device investment opportunities in China and providing the capital, connections and leadership to help entrepreneurs realize their vision. www.ChinaBioLLC.com
Successfully held at Hong Kong Science Park!
Copyright © 2013, ChinaBio® LLC - ChinaBio is a registered trademark of ChinaBio® LLC